Oriderma ointment
Natural health product licensed in Canada
- Licence holder
- Orimed Pharma Inc.
- NPN or DIN-HM
- 80065649
- Status
- Active licence
- Licence date
- 2 December 2015
- Revision date
- Not provided
- Form
- Onguent
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Boswellia sacra Source : Gum oleoresin | 2.8 % |
| Oxyde de zinc Source : Oxyde de zinc | 16 % |
| Huile de foie de morue Source : Poisson d'huile de foie de morue-Foie | 15 % |
| Aloe vera Source : Latex | 1 % |
| Melaleuca alternifolia Source : Feuille | 2 % |
| Lavandula angustifolia Source : Lavandula angustifolia - Sommité en fleurs (herbe) | 0.4 % |
| Lanoline Source : Ovis Aries - laine | 20 % |
Non-medicinal ingredients
Eau, Pétrolatum blanc, Huile minérale légère, Paraffine dure
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Onguent | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Oriderma ointment can be used in the management of uncomplicated wounds to help improve healing. Oriderma ointment helps reduce erythema and pruritus in the management of superficial wounds. Dries the oozing and weeping and helps relieve minor skin irritation and itching due to poison ivy, poison oak and poison sumac. Temporarily protects and helps relieve minor skin irritation and itching of minor cuts, scrapes and burns.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80065649
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.